AKT1 and neoplasm: Previous studies have identified LINC01554 as a liver-enriched tumor suppressor lncRNA that regulates glucose metabolism by promoting PKM2 degradation and inhibiting the Akt/mTOR pathway, thereby suppressing HCC progression [41].